Enento Group Oyj
ENENTO GROUP PLC, STOCK EXCHANGE RELEASE ON 9 MARCH 2021 AT 12.00 EET
Enento Group Plc - Managers' transactions - Koivula
____________________________________________
Person subject to the notification requirement
Name: Koivula, Heikki
Position: Other senior manager
Issuer: Enento Group Plc
LEI: 743700EPLUWXE25HGM03
Notification type: INITIAL NOTIFICATION
Reference number: 743700EPLUWXE25HGM03_20210309102951_22
____________________________________________
Transaction date: 2021-03-01
Venue not applicable
Instrument type: SHARE
ISIN: FI4000123195
Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE
Transaction details
(1): Volume: 2576 Unit price: 0.00 EUR
Aggregated transactions
(1): Volume: 2576 Volume weighted average price: 0.00 EUR
ENENTO GROUP PLC
For further information:
Pia Katila
Investor Relations Manager
Tel. +358 10 270 7506
Distribution:
Nasdaq Helsinki
Major media
enento.com/investors
Enento Group is a Nordic knowledge company powering society with intelligence since 1905. We collect and transform data into intelligence and knowledge used in interactions between people, businesses and societies. Our digital services, data and information empower companies and consumers in their daily digital decision processes, as well as financial processes and sales and marketing processes. Approximately 425 people are working for Enento Group in Finland, Norway, Sweden and Denmark. The Group’s net sales for 2020 was 151,3 MEUR. Enento Group is listed on Nasdaq Helsinki with the trading code ENENTO.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Purespring Therapeutics9.7.2025 08:00:00 CEST | Press release
Purespring Therapeutics announce FDA IND clearance for Phase I/II clinical trial for primary IgA nephropathy (IgAN)
FLSmidth A/S9.7.2025 07:30:53 CEST | Press release
Transactions under share buy-back programme
Fingerprint Cards AB8.7.2025 22:20:54 CEST | Press release
Postponement of Reverse Share Split in Fingerprint Cards AB (publ) due to technical reasons
Oil-Dri Corporation Of America8.7.2025 22:00:45 CEST | Press release
Oil-Dri Corporation of America Appoints Dr. Mervyn de Souza as Vice President of Research & Development
KingsRock Advisors, LLC.8.7.2025 21:48:02 CEST | Press release
UPDATE - KingsRock Advisors Announces Dr. Josef Ackermann as Chairman of New Advisory Board, Additional Senior Hires and Senior Advisors, and Inaugural Capital Raise
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom